Phenylpropanolamine (PPA) Information Page
The Food and Drug Administration (FDA) is taking steps to remove phenylpropanolamine (PPA) from all drug products and has requested that all drug companies discontinue marketing products containing PPA. In addition, FDA has issued a public health ... [... more]
Food & Drug Administration |
Unapproved Timed-Release Guaifenesin Products
FDA will take action against companies that market unapproved drug products in time-release dosage form that contain guaifenesin. On May 25, 2007, FDA announced that it will take action against companies that market unapproved drug products in ... [... more]
Food & Drug Administration |
OTC Cough and Cold Products:
FDA strongly recommends that over-the-counter (OTC) cough and cold products should not be used in infants and children under 2 years of age. A. FDA strongly recommends that over-the-counter (OTC) cough and cold products should not be used for ... [... more]
Food & Drug Administration |
